ArticleClinical oral investigations2025
The impact of methylphenidate on oral health parameters, salivary flow rate, and quality of life in children with attention-deficit/hyperactivity disorder: a cross-sectional study.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07774806 (Postoperative Pain Following Total Pulpotomy With Two Repair Cements in Carious Hypomineralized Teeth With Irreversible Pulpitis), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Postoperative Pain Following Total Pulpotomy With Two Repair Cements in Carious Hypomineralized Teeth With Irreversible Pulpitis: A Randomized Clinical Trial
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesThis study aimed to evaluate and compare the effects of methylphenidate on oral health, salivary flow rate, and quality of life in children with Attention-Deficit/Hyperactivity Disorder (ADHD), focusing on differences between short-release methylphenidate (SRM) and long-release methylphenidate (LRM) formulations. MATERIALS AND
methodsA total of 99 children participated in this cross-sectional study (ADHD: n = 49; divided into SRM (n = 27) and LRM (n = 22) subgroups based on medication type; control: n = 50). Dental caries was assessed using the DMFT/dft indices and the International Caries Detection and Assessment System (ICDAS), while oral hygiene was evaluated using the Plaque Index (PI), Gingival Index (GI), and Bleeding on Probing (BOP). Unstimulated salivary flow rates were measured. Salivary Streptococcus mutans and Lactobacillus levels were quantified using quantitative real-time polymerase chain reaction (qPCR). Quality of life was assessed with the Child Perceptions Questionnaire (CPQ) and KIDSCREEN-10. Logistic regression analyses examined associations between oral health outcomes, ADHD status, and medication type.
resultsThe ADHD group, especially SRM users, showed significantly higher DMFT scores, poorer oral hygiene, and reduced salivary flow rates compared to controls. Regression models further identified increased BOP and decreased salivary flow as predictors of ADHD and SRM use. qPCR confirmed higher Streptococcus mutans levels in SRM users. Quality of life was lower in ADHD children, particularly older SRM users.
conclusionsChildren with ADHD receiving methylphenidate exhibited poorer oral health and reduced quality of life, especially with SRM formulations. CLINICAL RELEVANCE: Clinicians should be aware that children-particularly those receiving SRM-are more likely to present with reduced salivary flow, increased plaque accumulation, and gingival inflammation. Regular dental monitoring, reinforcement of oral hygiene practices, and dietary counseling should be integrated into the care plans of these patients.
Indexed as
Identifiers
40906299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.